BCSP Bowel Cancer Screening Programme, bowel cancer, colorectal cancer, disease, NHS national health service, epidemiology
Bowel cancer sometimes referred to as colorectal cancer (CRC) is a disease that can be caused due to a multitude of factors. Statistically, it is known to be the third most diagnosed cancer after breast cancer and lung cancer (National Cancer Institute, 2013). CRC is also known to cause the second most cancer-related deaths in the world (Duan et al., 2022). There are between 1 to 2 million cases being diagnosed every year with exceeds of 700,000 deaths each year. CRC ranks as the second most common cancer in women (9.2%) and the third in men (10%) (Mármol et al., 2017). CRC is usually diagnosed between the ages of 65 and 74, due to this the American College of Physicians (ACP) recommend CRC screening should start from the age of 50 to 75.
[...] Evaluate and Discuss the Current UK Bowel Cancer Screening Programme Bowel cancer sometimes referred to as colorectal cancer (CRC) is a disease that can be caused due to a multitude of factors. Statistically, it is known to be the third most diagnosed cancer after breast cancer and lung cancer (National Cancer Institute, 2013). CRC is also known to cause the second most cancer-related deaths in the world (Duan et al., 2022). There are between 1 to 2 million cases being diagnosed every year with exceeds of 700,000 deaths each year. [...]
[...] J., Von Wagner, C. and Rees, C. J. (2017) The NHS bowel cancer screening program: Current perspectives on strategies for improvement, Risk Management and Healthcare Policy. 5. Kumar, R. and Lewis, C. R. (2022) Colon Cancer Screening, In StatPearls [Internet], StatPearls Publishing, [online] Available at: https://www.ncbi.nlm.nih.gov/books/NBK559064/ (Accessed 14 February 2024). 6. Mármol, I., Sánchez-de-Diego, C., Dieste, A. P., Cerrada, E. and Yoldi, M. [...]
[...] Another limitation of the FIC is there is a risk of missing the cancer if it was not bleeding when the FIT test was taken. The demand for follow-up colonoscopies can have a strain on the resources causing more wait times impacting patient care, especially in cases wherein immediate action is necessary. Public awareness and education about CRC play a crucial role in the willingness of people to participate in regular home-based tests, lack of this can lead to lowered participation rates leading to higher mortality rates. [...]
[...] and Crosbie, P. (2023) Defining the road map to a UK national lung cancer screening programme, The Lancet Oncology. 10. Oldfield, L., Stott, M., Hanson, R., Jackson, R. J., Reynolds, W., Chandran-Gorner, V., Van Der Meer, R., Alison, L., Tejeiro, R., Purewal, T., Ghaneh, P., Palmer, D., Greenhalf, W., Halloran, C. and Costello, E. (2022) United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer, BMJ Open, 12(10). [...]
[...] In conclusion, the NHS Bowel Cancer Screening Programme (BCSP), initiated in 2006, represents a significant effort in combating colorectal cancer (CRC) in the UK. Through its transition from gFOBt to the more sensitive FIT testing, the programme has enhanced the early detection and management of CRC. This strategic approach has led to a decrease in mortality rates and a shift towards diagnosing cancer at more treatable stages. However, the BCSP faces challenges such as lower participation rates and potential limitations of the FIT test, including false positives and negatives. [...]
APA Style reference
For your bibliographyOnline reading
with our online readerContent validated
by our reading committee
